Net Cash Provided by (Used in) Financing Activities in USD of Apyx Medical Corp from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Apyx Medical Corp quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • Apyx Medical Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $25,000.
  • Apyx Medical Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $6,745,000, a 79% decline from 2023.
  • Apyx Medical Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $32,166,000, a 14723% increase from 2022.
  • Apyx Medical Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $217,000, a 804% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Apyx Medical Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $25,000 +$30,000 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $5,000 -$8,117,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $8,112,000 +$8,014,000 +8178% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $98,000 +$159,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $61,000 -$76,000 -507% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $15,000 -$52,000 -78% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q1 2019 $67,000 +$127,000 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $60,000 -$1,000 -1.7% 01 Jan 2018 31 Mar 2018 10-Q/A 08 May 2020 2019 Q1
Q1 2017 $59,000 +$2,000 +3.3% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $61,000 -$11,769,000 -101% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q1 2015 $11,708,000 +$11,794,000 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q1 2014 $86,000 -$70,000 -438% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q1 2013 $16,000 +$16,000 +50% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q1 2012 $32,000 +$3,000 +8.6% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q1 2011 $35,000 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1

Apyx Medical Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,745,000 -$25,421,000 -79% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $32,166,000 +$31,949,000 +14723% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $217,000 +$193,000 +804% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $24,000 +$97,000 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $73,000 -$220,000 -150% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $147,000 +$2,639,000 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $2,492,000 -$2,253,000 -943% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2020 2019 FY
2017 $239,000 -$5,953,000 -104% 01 Jan 2017 31 Dec 2017 10-K 31 Mar 2020 2019 FY
2016 $5,714,000 -$7,065,000 -55% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
2015 $12,779,000 +$13,923,000 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
2014 $1,144,000 -$8,030,000 -117% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $6,886,000 +$7,016,000 01 Jan 2013 31 Dec 2013 10-K 18 Mar 2016 2015 FY
2012 $130,000 +$172,000 +57% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $302,000 -$1,979,000 -118% 01 Jan 2011 31 Dec 2011 10-K/A 08 May 2014 2013 FY
2010 $1,677,000 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.